Glioblastoma neoangiogenesis resulting from changes in EGFR, PDGFR, and VEGFR expression is commonly associated with phosphatidylinositide-3-kinase (PI3K) and mitogen-activated protein kinase (MAPK) signaling pathways under ROS activation [34,35]. The gene discussed is KDR; the disease is glioblastoma.